Chugai Files New Drug Application In Japan For Crovalimab For Paroxysmal Nocturnal Hemoglobinuria
14/06/2023 11:06
June 14 (Reuters) - Chugai Pharmaceutical Co Ltd
4519.T :
* CHUGAI PHARMACEUTICAL CO LTD: CHUGAI FILES NEW DRUG
APPLICATION
IN JAPAN FOR CROVALIMAB FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Source text for Eikon: ID:
Further company coverage: 4519.T
(Reporting by Tokyo Newsroom)
((+81345201189;))
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)